Constellation Pharmaceuticals (CNST) PT Raised to $42 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams raised the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $42.00 (from $20.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
